+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Stretching the mutant prevention concentration (MPC) beyond its limits



Stretching the mutant prevention concentration (MPC) beyond its limits



Journal of Antimicrobial ChemoTherapy 51(6): 1323-1325



The in vitro antifungal activity of albendazole, a benzimidazole widely used as an antihelmintic drug in humans, was investigated and assessed for its activity against Aspergillus spp.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 011403678

Download citation: RISBibTeXText

PMID: 12716780

DOI: 10.1093/jac/dkg255


Related references

Mutant prevention concentration and mutant selection window for 10 antimicrobial agents against Rhodococcus equi. Veterinary Microbiology 166(3-4): 670-675, 2013

New concepts in antimicrobial susceptibility testing: the mutant prevention concentration and mutant selection window approach. Veterinary Dermatology 20(5-6): 383-396, 2009

Determination of the Mutant Prevention Concentration and the Mutant Selection Window of Topical Antimicrobial Agents against Propionibacterium acnes. ChemoTherapy 62(2): 94-99, 2017

Comparison of the minimum inhibitory concentration , mutant prevention concentration and minimum bactericidal concentration of ciprofloxacin and levofloxacin against enteric gram-negative bacilli. Abstracts of the Interscience Conference on Antimicrobial Agents and Chemotherapy 42: 154, 2002

Comparative mutant prevention concentration and mutant selection window of sitafloxacin versus other quinolones using strains of Haemophilus influenzae with decreasing susceptibility to levofloxacin. International Journal of Antimicrobial Agents 33(5): 489-490, 2009

The mutant prevention concentration for ciprofloxacin and levofloxacin against non-urinary isolates of Pseudomonas aeruginosa and the relationship to achievable serum drug concentration following IV dosing. Abstracts of the Interscience Conference on Antimicrobial Agents and Chemotherapy 43: 119, 2003

Comparative mutant prevention concentration and minimal inhibitory concentration of gatifloxacin , gemifloxacin , levofloxacin and moxifloxacin against 101 isolates of methicillin-susceptible Staphylococcus aureus. Abstracts of the Interscience Conference on Antimicrobial Agents and Chemotherapy 42: 154-155, 2002

Predictors of bacterial resistance using in vitro dynamic models: area under the concentration-time curve related to either the minimum inhibitory or mutant prevention antibiotic concentration. Journal of Antimicrobial ChemoTherapy 71(3): 678-684, 2016

Low correlation between MIC and mutant prevention concentration. Antimicrobial Agents and ChemoTherapy 50(1): 403-404, 2006

Overstretching the mutant prevention concentration. Journal of Antimicrobial ChemoTherapy 52(4): 732; Author Reply 732-3, 2003

Mutant prevention concentration of pradofloxacin against Porphyromonas gingivalis. Veterinary Microbiology 121(1-2): 194-195, 2007

Mutant Prevention Concentration: is it significant in the clinical practice?. Le Infezioni in Medicina 16 Suppl 2: 12-21, 2008

Mutant prevention concentration of fluoroquinolones for Stenotrophomonas maltophilia. Zhongguo Kangshengsu Zazhi 31(4): 216-219, 2006

Determination of mutant prevention concentration of cefquinome against Escherichia coli. 2008